BackIntech Biopharm Overview
Intech Biopharm Corporation

Intech Biopharm PEG Ratio

Latest PEG ratio for Intech Biopharm: -2.63 — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

PEG Ratio

-2.63

PEG Ratio

-2.63

The PEG ratio measures a stock's valuation relative to its earnings growth rate. A PEG ratio below 1.0 may indicate that the stock is undervalued relative to its growth potential.

PEG Ratio (Comparison Companies)

Loading

PEG Ratio History

Loading

PEG Ratio Comparison

Loading

Intech Biopharm (6461.TWO) FAQ

The latest PEG ratio for 6461.TWO is -2.63. That is above the Healthcare sector average of -6.46. Investors often review this figure alongside Intech Biopharm's historical trend and sector peers before judging valuation or financial health.

Against Healthcare companies, 6461.TWO currently prints -2.63 for PEG ratio, while the sector average sits near -6.46. That is roughly 59.3% above the sector mean. Large gaps often invite a closer look at Intech Biopharm's growth, margins, and balance sheet.

A PEG ratio of -2.63 for Intech Biopharm is not 'good' or 'bad' on its own. Compare it with the peer average (-6.46) and with 6461.TWO's multi-year chart on this page. Persistently elevated multiples need growth or quality to justify them; depressed multiples need a catalyst or evidence the business is misunderstood.

After noting 6461.TWO's PEG ratio (-2.63), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.

This page's peer comparison chart is the fastest way to stack Intech Biopharm's PEG ratio against similar Healthcare names. You can also browse sector and industry screens on Stockcircle for a broader set of Healthcare companies and their key multiples and fundamentals.